skip to main content


Schizophrenia Division

The Schizophrenia Division specializes in the treatment and study of individuals with schizophrenia and related psychotic disorders. Training and educational experiences are provided to students from the Faculty of Health Sciences including Medicine, Nursing and Social Work, residents training in Psychiatry and Psychology, and graduate students. Affiliated neuroscience laboratories study molecular mechanisms that underlie psychosis. The Division is based at St. Joseph’s Healthcare Hamilton where there are extensive specialized inpatient and outpatient services devoted to the care of individuals with schizophrenia including a specialized early intervention service and ACTT teams. Clinical research in the Division is focused on improving outcomes and enhancing recovery from schizophrenia.


  • Development of the Canadian Objective Assessment of Life Skills (COALS) which is a unique and focused assessment of practical thinking and skills needed for key aspects of daily life in people with schizophrenia.
  • Investigating exceptionality and cognitive impairment in schizophrenia study to determine the extent to which cognitive performance and illness severity in schizophrenia are truly separable.
  • Development of an interactive novel and adventure-style videogame that promotes an understanding of psychosis, the risk associated with marijuana use among adolescence and where youth can go to seek help for emerging psychosis.
  • Studying rTMS as an intervention for auditory hallucinations that do not resolve with antipsychotic medication
  • Investigating  the application  of therapeutic blood level monitoring for optimizing maintenance treatment and relapse prevention in schizophrenia.
  • Characterizing patient-centred outcome priorities in order to better understand what clinical outcomes are of most importance to people living with schizophrenia

Application to Consumer

Faculty members of the Schizophrenia Division are integrated into the clinical services of the Schizophrenia and Community Integration Service at St. Joseph’s Healthcare Hamilton. In addition to providing care to people living with schizophrenia across the adult age range, faculty interact with community agencies and the local health integration network (LHIN) to provide specialized tertiary services for individuals with schizophrenia in our community and throughout the Niagara Region.

Other Faculty

  • Suzanne Archie MD
    • Areas of interest from previous website are: Her research interests include program evaluation, shared care with primary care health providers, lifestyle changes for antipsychotic induced weight gain and first episode psychosis research.
  • Henry Bibr MD
  • Peter Cook MD
  • JoAnn Corey MD
  • Margaret Fahnestock PhD
    • Areas of research interest from previous website are: Regulation of neurotrophic factors and their precursors. Role and regulation of NGF and BDNF in Alzheimer’s disease, epilepsy, and autism. Peripheral nerve injury.
  • Sarah Garside MD PhD
  • Jeremy Goldberg MD
  • Jelena King PhD
  • Stephen List MD
  • Rod Lough MD
  • Stephanie McDermid Vaz PhD
    • Areas of research interest include assessment of neuropsychological functioning and functional outcomes.
  • Sandra McNally PhD
    • Research interest - psychotherapeutic treatment of psychotic disorders, including the phenomenology of voice hearing and delusions.
  • Heather McNeely PhD
    • Dr. McNeely’s research interests focus in two main areas: 1) the impact of emotional salience on neuropsychological processes and 2) longitudinal changes in neuropsychological functioning associated with neurobiological interventions for psychiatric conditions
  • Bruce Menchions MD
  • Natasja Menezes MD
    • Dr. Menezes' research interests are in early intervention in psychosis, the early phase of schizophrenia, and determinants of illness and outcome.
  • Ram Mishra PhD
    • Dr. Mishra’s interest is in the relationship between genetic, biochemical and molecular mechanisms and neuropsychiatric disorders such as schizophrenia; drug induced oxidative stress, and Parkinson’s diseases.
  • Ed Rotstein MD
  • Michal Siekerski MD
  • Susan Strong PhD
  • Albina Veltman MD 
  • © 2018 McMaster University | 1280 Main Street West | Hamilton, Ontario L8S4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy